Cited by 3,185COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Dermatological and COVID-19 studies

Extrapulmonary manifestations of COVID-19

Open access
Gupta, Aakriti, Madhavan, Mahesh V., Sehgal, Kartik, Nair, Nandini, Mahajan, Shiwani, Sehrawat, Tejasav S., Bikdeli, Behnood, Ahluwalia, Neha +21 more·2020·Nature Medicine

Abstract

Although COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations. These conditions include thrombotic complications, myocardial dysfunction and arrhythmia, acute coronary syndromes, acute kidney injury, gastrointestinal symptoms, hepatocellular injury, hyperglycemia and ketosis, neurologic illnesses, ocular symptoms, and dermatologic complications. Given that ACE2, the entry receptor for the causative coronavirus SARS-CoV-2, is expressed in multiple extrapulmonary tissues, direct viral tissue damage is a plausible mechanism of injury. In addition, endothelial damage and thromboinflammation, dysregulation of immune responses, and maladaptation of ACE2-related pathways might all contribute to these extrapulmonary manifestations of COVID-19. Here we review the extrapulmonary organ-specific pathophysiology, presentations and management considerations for patients with COVID-19 to aid clinicians and scientists in recognizing and monitoring the spectrum of manifestations, and in developing research priorities and therapeutic strategies for all organ systems involved.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-020-0968-3

Cites

221 of 221 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • COVID-19 is heterogeneous, with courses from asymptomatic or mild to severe or critical in 10%-20% of symptomatic patients, who face substantial fatality risk and involvement of multiple organ systems.

    “Disease courses range from mainly asymptomatic and mild courses to more severe and critical courses in 10%–20% of symptomatic patients who are at considerable risk of fatality with many different organ systems involved in differing combinations and with variable symptoms (Gupta et al., 2020)”

    From COVID-19 and the human innate immune system (2021) · cites this paper as Gupta et al., 2020

  • SARS-CoV-2 facilitates release of coagulation factors, secretion of inflammatory cytokines, and formation of leukocyte-platelet aggregates, which might be important mechanisms leading to thromboembolic complications in severe COVID-19.

    “Furthermore, the virus facilitates the release of coagulation factors, the secretion of inflammatory cytokines, and the formation of leukocyte-platelet aggregates, which might be important mechanisms leading to thromboembolic complications observed in severe COVID-19 (Ackermann et al., 2020; Gupta et al., 2020; Zhang et al., 2020b).”

    From COVID-19 and the human innate immune system (2021) · cites this paper as Gupta et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 19

  1. [58]Ranucci M The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J. Thromb. Haemost. 10.1111/jth.1485 (2020). PMC9906332 32302448 · DOI
  2. [62]Ye M Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 17, 3067– 3075 (2006). 17021266
  3. [71]Fan BE Hematologic parameters in patients with COVID-19 infection. Am. J. Hematol. 10.1002/ajh.25774 (2020). PMC7267477 32339335 · DOI
  4. [79]Helms J Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. (2020). 32453517
  5. [86]Poissy J Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 10.1161/CIRCULATIONAHA.120.047430 (2020). 32330083 · DOI
  6. [98]Lax SF Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann. Intern. Med. 10.7326/M20-2566 (2020). PMC7249507 32422076 · DOI
  7. [99]Wichmann D Autopsy findings and venous thromboembolism in patients with COVID-19. Ann. Intern. Med. 10.7326/M20-2003 (2020). 33316197 · DOI
  8. [106]Clerkin KJ Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation 141, 1648– 1655 (2020). 32200663
  9. [116]Epelman S Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J. Am. Coll. Cardiol. 52, 750– 754 (2008). 18718423 PMC2856943
  10. [131]Yang G Effects of ARBs and ACEIs on virus infection, inflammatory status and clinical outcomes in COVID-19 patients with hypertension: a single center retrospective study. Hypertension 76, 51– 58 (2020). 32348166
  11. [134]Welt FGP Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from the ACC’s Interventional Council and SCAI. J. Am. Coll. Cardiol. 75, 2372– 2375 (2020). 32199938 PMC7270593
  12. [151]Larsen CP, Bourne TD, Wilson JD, Saqqa O & Sharshir MA Collapsing glomerulopathy in a patient with coronavirus disease 2019 (COVID-19). Kidney Int. Rep. 5, 935– 939 (2020). 32292867 PMC7142700
  13. [176]Wu Z & McGoogan JM Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. J. Am. Med. Assoc. 323, 1239– 1242 (2020). 32091533
  14. [188]Simonnet A High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity 10.1002/oby.2283 (2020). PMC7262326 32271993 · DOI
  15. [189]McClean KM, Kee F, Young IS & Elborn JS Obesity and the lung: 1. Epidemiol. Thorax 63, 649– 654 (2008). 18587034
  16. [199]Pilotto A Steroid-responsive encephalitis in Covid-19 disease. Ann. Neurol. (2020). PMC7276848 32418288
  17. [209]AHA/ASA Stroke Council Leadership. Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic: On Behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke 51, 1910– 1912 (2020). 32233972
  18. [228]Gordon JB, Kahn AM & Burns JC When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. J. Am. Coll. Cardiol. 54, 1911– 1920 (2009). 19909870 PMC2870533
  19. [246]Patanè L Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth. Am. J. Obstet. Gynecol 10.1016/j.ajogmf.2020.100145 (2020). PMC7233206 32427221 · DOI

Cited by

Sorted by citations

Authors
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., Freedberg, D. E., Kirtane, A. J., Parikh, S. A., Maurer, M. S., Nordvig, A. S., Accili, D., Bathon, J. M., Mohan, S., Bauer, K. A., Leon, M. B., Krumholz, H. M., Uriel, N., Mehra, M. R., Elkind, M. S. V., Stone, G. W., Schwartz, A., Ho, D. D., Bilezikian, J. P., & Landry, D. W.
Affiliations
  • Yale New Haven Hospital (US)
  • Columbia University Irving Medical Center (US)
  • Beth Israel Deaconess Medical Center (US)
  • Mayo Clinic (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Cardiovascular Research Foundation (US)
  • NewYork–Presbyterian Hospital (US)
  • Brigham and Women's Hospital (US)
  • Aaron Diamond AIDS Research Center (US)
Corresponding author
Landry, Donald W.
Venue
Nature Medicine
Published
2020-07
Volume
26
Issue
7
Pages
1017-1032
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3040801404
Cited by
3,185
References
221
Citations by year
2026: 125 · 2025: 182 · 2024: 333 · 2023: 558 · 2022: 751 · 2021: 965 · 2020: 261 · 2019: 2 · 2018: 4 · 2015: 1
FWCI
29.68
Type
journal article
Language
en
Open access
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Health & Human Services | National Institutes of Health (T32 - HL007854, K23- DK111847)
  • U.S. Department of Defense (PR-181960)
  • U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (5T32 - NS007153)
  • U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 - AR050026, U01- AR068043)
  • U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 - MD014161, U01- DK116066)
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K08-HL122526, R01 - HL152236, R03 - HL146881)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
Keywords
COVID-19 pandemic, SARS-CoV-2, extrapulmonary manifestations, thrombotic complications, cardiac dysfunction, cardiac arrhythmias, acute coronary syndrome, acute kidney injury, gastrointestinal symptoms, hepatocyte injury, hyperglycemia, ketosis, neurological complications, ocular symptoms, skin complications, ACE2 receptor, thromboinflammation, endothelial injury, immune dysregulation
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Endothelium, Vascular, Humans, Inflammation, Organ Specificity, Pneumonia, Viral, Renin-Angiotensin System, Thrombosis, Coronavirus Infections, Disease Progression, Virus Internalization, Adaptive Immunity, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review